Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study

被引：0
|
作者：
Michael Borte
Isaac R. Melamed
Grazyna Pulka
Barbara Pyringer
Alan P. Knutsen
Hans D. Ochs
Roger H. Kobayashi
Ai Lan Kobayashi
Sudhir Gupta
Magdalena Strach
William Smits
Anna Pituch-Noworolska
James N. Moy
机构：
[1] Klinikum St. Georg gGmbH,Klinik für Kinder
[2] Hospital St. Georg gGmbH Leipzig, und Jugendmedizin
[3] IMMUNOe Research Center Centennial,Immunodeficiency Centre Leipzig (IDCL)
[4] Uniwersytetu Jagiellońskiego,Klinika Alergologii Collegium Medicum
[5] Octapharma Pharmazeutika Produktionsges.m.b.H,Clinical Research and Development Department
[6] Saint Louis University,Department of Pediatrics
[7] University of Washington and Seattle Children’s Research Institute,Division of Pediatric Allergy/Immunology
[8] UCLA School of Medicine,undefined
[9] University of California,undefined
[10] Jagiellonian University Medical College,undefined
[11] The Allergy and Asthma Center,undefined
[12] University Children Hospital,undefined
[13] Stroger Hospital of Cook County,undefined
来源：
Journal of Clinical Immunology | 2017年 / 37卷
关键词：
Primary immunodeficiency diseases; intravenous immunoglobulin; panzyga®; serious bacterial infections;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：603 / 612
页数：9
相关论文
共 50 条
  • [41] Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia: Results of an open-label multicenter study in Japan
    Ishigooka, J
    Murasaki, M
    Miura, S
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2001, 55 (04) : 353 - 363
  • [42] Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open-label study
    Hide, Michihiro
    Ohsawa, Isao
    Nurse, Christina
    Yu, Ming
    JOURNAL OF DERMATOLOGY, 2023, 50 (11): : 1381 - 1391
  • [43] Efficacy, Pharmacokinetics, Safety, and Tolerability of Flebogamma® 10% DIF, a High-Purity Human Intravenous Immunoglobulin, in Primary Immunodeficiency
    Melvin Berger
    Paul J. Pinciaro
    Arthur Althaus
    Mark Ballow
    Akhilesh Chouksey
    James Moy
    Hans Ochs
    Mark Stein
    Journal of Clinical Immunology, 2010, 30 : 321 - 329
  • [44] Efficacy, Pharmacokinetics, Safety, and Tolerability of FlebogammaA® 10% DIF, a High-Purity Human Intravenous Immunoglobulin, in Primary Immunodeficiency
    Berger, Melvin
    Pinciaro, Paul J.
    Althaus, Arthur
    Ballow, Mark
    Chouksey, Akhilesh
    Moy, James
    Ochs, Hans
    Stein, Mark
    JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 (02) : 321 - 329
  • [45] Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study
    Yamamoto, Eiichiro
    Usuku, Hiroki
    Sueta, Daisuke
    Suzuki, Satoru
    Nakamura, Taishi
    Matsui, Kunihiko
    Matsushita, Kenichi
    Iwasaki, Tomoko
    Sakaino, Naritsugu
    Sakanashi, Toshihiko
    Hirayama, Kazuto
    Kurokawa, Hirofumi
    Kikuta, Koichi
    Yamamoto, Nobuyasu
    Sato, Koji
    Tokitsu, Takanori
    Taguchi, Takashi
    Shiosakai, Kazuhito
    Sugimoto, Kotaro
    Tsujita, Kenichi
    ADVANCES IN THERAPY, 2024, 41 (03) : 1284 - 1303
  • [46] Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study
    Eiichiro Yamamoto
    Hiroki Usuku
    Daisuke Sueta
    Satoru Suzuki
    Taishi Nakamura
    Kunihiko Matsui
    Kenichi Matsushita
    Tomoko Iwasaki
    Naritsugu Sakaino
    Toshihiko Sakanashi
    Kazuto Hirayama
    Hirofumi Kurokawa
    Koichi Kikuta
    Nobuyasu Yamamoto
    Koji Sato
    Takanori Tokitsu
    Takashi Taguchi
    Kazuhito Shiosakai
    Kotaro Sugimoto
    Kenichi Tsujita
    Advances in Therapy, 2024, 41 : 1284 - 1303
  • [47] Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: An open-label, multicenter, prospective study
    Chung, Jae Hoon
    Lee, Joo Yong
    Kang, Dong Hyuk
    Ha, U-Syn
    Lee, Seung Hwan
    Ham, Won Sik
    Cho, Kang Su
    Han, June Hyun
    Park, Jinsung
    Yoo, Tag Keun
    Lee, Seung Wook
    NEUROUROLOGY AND URODYNAMICS, 2012, 31 (07) : 1175 - 1180
  • [48] The Efficacy and Safety of Imusil® Tablets in the Treatment of Adult Patients With Mild COVID19: A Prospective, Randomized, Multicenter, Open-Label Study
    Abhyankar, Mahesh
    Kadam, Dilip
    Reddy, P. Raghavendra
    Siddiqui, Mohammed Zaki
    Ratheesh, M.
    Jagmag, Tariq
    Tilwani, Jayesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [49] The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study
    Gottlieb, Alice B.
    Kalb, Robert E.
    Blauvelt, Andrew
    Heffernan, Michael P.
    Sofen, Howard L.
    Ferris, Laura Korb
    Kerdel, Francisco A.
    Calabro, Stephen
    Wang, Jim
    Kerkmann, Urs
    Chevrier, Marc
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (04) : 642 - 650
  • [50] Efficacy and safety of valsartan in reducing blood pressure and albuminuria in Chinese patients with essential hypertension: a multicenter prospective open-label observational study
    Zhang, Xiaoyan
    Ding, Xiaoqiang
    Cao, Guoliang
    Deng, Yueyi
    Xu, Xudong
    Li, Hui
    Zhuang, Xiaoming
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (10) : 1677 - 1684
12345